ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus

Med Oncol. 2003;20(4):409-12. doi: 10.1385/MO:20:4:409.

Abstract

Patients with systemic lupus erythematosus (SLE) appear to have an increased risk of developing malignancies, especially lymphomas. We report the development of a systemic ALK-negative T-cell anaplastic large cell lymphoma, stage IIB, in a 53-yr-old Caucasian female with a 12-yr history of stable SLE. The patient responded poorly to chemotherapy and died 2 yr after diagnosis. Lymphomas that develop in patients with SLE and other autoimmune diseases are virtually always of B-cell origin. To our knowledge this is the first report of a T-cell anaplastic large cell lymphoma in a patient with SLE. This article discusses the association of SLE and lymphoma, with an emphasis on T-lymphoproliferative states.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Carcinoma / drug therapy
  • Carcinoma / etiology*
  • Carcinoma / pathology
  • Fatal Outcome
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / complications*
  • Lymphoma, T-Cell / drug therapy
  • Lymphoma, T-Cell / etiology*
  • Lymphoma, T-Cell / pathology